Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

NeuroPath_media
medal 2
Ce profil est validé par 2 label.

Company

NeuroPath

NeuroPath_logo
29
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, QoL surveys, wearables and voice detection.

Enghien, Région wallonne, Belgium

Send a message

  • €25,000

    turnover

Anglais

NeuroPath

Anglais

NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, Quality of Life surveys, wearables and voice detection.

Using AI, data is analyzed and transformed into objective parameters of disease progression to create insights into care path adherence, treatment results, drug efficacy and personalized care that can be shared with all stakeholders.

...
See more

NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, Quality of Life surveys, wearables and voice detection.

Using AI, data is analyzed and transformed into objective parameters of disease progression to create insights into care path adherence, treatment results, drug efficacy and personalized care that can be shared with all stakeholders.

Due to its hardware agnostic approach, NeuroPath can develop algorithms by plugging in different sensors and data sets. This can also entail the incorporation of Internet of Thing (IoT) and invisible Patient Reported Outcomes (iPROs). A graphic user interface facilitates the consultation of the reports as well as the custom analytics of the results.

“I see my neurologist every six months for a thirty-minute session. That leaves 8,765 hours per year when my disease is not being monitored.” Parkinson’s disease is very complex, and the progression of the disease is highly individual. Therefore, the need for a constant visibility on the disease progression and the impact of the treatment regimen is crucial to the quality of life of the patient.

NeuroPath supports caregivers and clinicians in personalizing care pathways by engaging patients, significant others and the full ecosystem of clinicians around the patient. Eventually, big data will benefit pharma, CRO and payers. 

 

  • 3

    Followers

  • 1

    Like

Our latest news

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
161 Entities
ePitches EuroQuity
178 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1220 Members
EUROQUITY BELGIQUE
SOWALFIN AU SERVICE DE LA CROISSANCE DES ENTREPRISES La communauté est réservée aux entreprises soutenues par le Groupe Sowalfin et à ses partenaires
165 Members

Our history

Start in December 2016

  • December 2016

    NeuroPath signs 4 MoU’s during the Royal Mission in Texas, December 2016

  • September 2016 - January 2018

    Pilot project commitment at 3 hospitals in Belgium Project partners on board

  • February 2018 - Nov 2019

    600K equity and 300K non-dilutive grants raised Selected for CIM @ MATTER incubator Chicago

  • Q4 2019

    Agreements Texas A&M & Nortwestern Medicine InvestHorizon Accelerator Opening Chicago office

to be continued ...